Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Feb 8;55(2):188-189.
doi: 10.1016/j.immuni.2022.01.012. Epub 2022 Jan 22.

Response to Are NKT cells a useful predictor of COVID-19 severity?

Stefanie Kreutmair  1 , Burkhard Becher  2
Affiliations
Comment

Response to Are NKT cells a useful predictor of COVID-19 severity?

Stefanie Kreutmair et al. Immunity. .
No abstract available

PubMed Disclaimer

Comment on

  • Are NKT cells a useful predictor of COVID-19 severity?
    Koay HF, Gherardin NA, Nguyen THO, Zhang W, Habel JR, Seneviratna R, James F, Holmes NE, Smibert OC, Gordon CL, Trubiano JA, Kedzierska K, Godfrey DI. Koay HF, et al. Immunity. 2022 Feb 8;55(2):185-187. doi: 10.1016/j.immuni.2022.01.005. Epub 2022 Jan 19. Immunity. 2022. PMID: 35104438 Free PMC article. No abstract available.

References

    1. Flament H., Rouland M., Beaudoin L., Toubal A., Bertrand L., Lebourgeois S., Rousseau C., Soulard P., Gouda Z., Cagninacci L., et al. Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity. Nat. Immunol. 2021;22:322–335. - PubMed
    1. Godfrey D.I., MacDonald H.R., Kronenberg M., Smyth M.J., Van Kaer L. NKT cells: what’s in a name? Nat. Rev. Immunol. 2004;4:231–237. - PubMed
    1. Koay H.-F., Gherardin N.A., Nguyen T.H., Zhang W., Habel J.R., Seneviratna R., James F., Holmes N.E., Smibert O.C., Gordon C.L., et al. Are NKT cells a useful predictor of COVID-19 severity? Immunity. 2022;55:185–187. - PMC - PubMed
    1. Kreutmair S., Unger S., Núñez N.G., Ingelfinger F., Alberti C., De Feo D., Krishnarajah S., Kauffmann M., Friebel E., Babaei S., et al. Distinct immunological signatures discriminate severe COVID-19 from non-SARS-CoV-2-driven critical pneumonia. Immunity. 2021;54:1578–1593.e5. - PMC - PubMed
    1. Li M., Guo W., Dong Y., Wang X., Dai D., Liu X., Wu Y., Li M., Zhang W., Zhou H., et al. Elevated Exhaustion Levels of NK and CD8+ T Cells as Indicators for Progression and Prognosis of COVID-19 Disease. Front. Immunol. 2020;11:580237. - PMC - PubMed